Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Vanadium Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 757 records · Page 42Linked to original sources

Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.

Vanadium(IV) oxo-bis(maltolato) (BMOV), an organovanadium compound, is a potent insulinomimetic agent and improves glucose homeostasis in various models of diabetes. We have shown previously that BMOV stimulates the phosphorylation of PKB which may contribute as one of the mechanisms for the insulinomimetic effect of this compound. However, the upstream mechanism of BMOV-induced PKB phosphorylation remains elusive. Therefore, in this study, we examine the upstream events leading to BMOV-induced PKB phosphorylation in HepG2 cells. Since BMOV is an inhibitor of protein tyrosine phosphatases and through enhanced tyrosine phosphorylation may activate various protein tyrosine kinases (PTK), we have investigated the potential role of different receptor or nonreceptor PTK in mediating BMOV-induced PKB phosphorylation. Among several pharmacological inhibitors that were tested, only AG1024, a selective inhibitor of IGF-1R-PTK, almost completely blocked BMOV-stimulated phosphorylation of PKB. In contrast, AG1295 and AG1478, specific inhibitors of PDGFR and EGFR, respectively, were unable to block the BMOV response. Moreover, efficient reduction of the level of IGF-1R protein expression by antisense oligonucleotides (ASO) attenuated BMOV-induced PKB phosphorylation. BMOV-induced PKB phosphorylation was associated with an increased level of tyrosine phosphorylation of the IRbeta subunit, IGF-1Rbeta subunit, IRS-1, and p85alpha subunit of PI3-kinase. However, this response was independent of IR-PTK activity because in cells overexpressing a PTK-inactive form of IR, insulin response was attenuated while the effect of BMOV remained intact. A role of PKC in BMOV-induced response was also tested. Pharmacological inhibition with chelerythrine, a nonselective PKC inhibitor, or rottlerin, a PKCdelta inhibitor, as well as chronic treatment with PMA attenuated BMOV-induced PKB phosphorylation. In contrast, GO6976 and RO31-8220 PKCalpha/beta selective inhibitors failed to alter the BMOV effect. Taken together, these data suggest that IGF-1R and PKCdelta are required to stimulate PKB phosphorylation in response to BMOV in HepG2 cells and provide new insights into the molecular mechanism by which this compound exerts its insulinomimetic effects.

Animals↗

Electrochemical Properties and ESR Characterization of Mixed Valence alpha-[XMo(3)(-)(x)()V(x)()W(9)O(40)](n)()(-) Heteropolyanions with X = P(V) and Si(IV), x = 1, 2, or 3.

Electrochemical behavior of the alpha-[SiMo(3)(-)(x)()V(x)()W(9)O(40)]((4+)(x)()())(-) and alpha-[PMo(3)(-)(x)()V(x)()W(9)O(40)]((3+)(x)()())(-) anions with x = 1, 2, or 3 were studied. Electrochemical reduction of each compounds was consistent with its Mo/V ratio, reduction of vanadium and molybdenum atoms occurring in the +0.6 to -0.6 V potential range. The one-electron-reduced species were prepared by electrolysis and then characterized by ESR spectroscopy. The g and A values for V(4+)ions appeared to depend on the nature of the surrounding atoms (Mo(VI), W(VI), and V(V)). In solution at 330 K, the ESR spectrum of the protonated alpha-H[SiMoV(IV)VW(9)O(40)](6)(-) anion displayed 29 superhyperfine lines which were related to the partial localization of the electron on one vanadium nucleus. The ESR spectra at room temperature for the divanadium-substituted anions showed a strong anisotropy of the A tensor which would be related to the electron transfer along a preferential axis. An isolated V(4+) signal was not observed, even at 12 K, indicating that the electron is never firmly trapped on one single vanadium atom.

Journal Article↗

Oligomerization of early transition metal [M(OH)3]2(mu-C2) acetylides toward the formation of [(OH)3MC]n (n = 4, 6) metalla carbides: a theoretical study by density functional theory.

Density functional calculations were performed on a series of M(OH3)-substituted (M = Ti,V) cyclopolyenes as simple models is metal carbides. We studied the oligomerization of the metal acetylide complexes [MLn]2 (mu-C2) as a possible precursor of these [(OH)3MC]n (n = 4,6) hypothetical species. Special emphasis was placed on the comparison of the main properties of these metal substituted cyclopolyenes with those of the corresponding cyclopolyenes in an attempt to study the effects of the metal substituents on the organic C4 and C6 cyclic moieties. Whereas for the titanium species, the pi system of the polyene moiety is slightly perturbed, the electronic structures and molecular geometries found for the vanadium species suggest a metalla radialene nature for these compounds, with the endocyclic conjugation of carbon-carbon double bonds replaced by an exocyclic arrangement of carbon-metal double bonds.

Journal Article↗

Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.

The element vanadium can have insulin mimetic properties and therefore has been suggested as a possible therapeutic agent for treatment of diabetes. A series of peroxovanadium compounds that are more potent at lowering blood glucose levels than sodium metavanadate, sodium orthovanadate and vanadyl sulfate have recently been synthesized. These compounds probably will not be orally active so transdermal administration is a potential option. A patch containing either the peroxovanadium compound [VO(O2)2 1-10 phenanthroline], abbreviated bpV(phen), or placebo was placed on the back of streptozotocin induced diabetic rats and was delivered either passively (16 h) or iontophoretically (0.5 mA/cm2 for 4 h). Blood samples were analyzed for glucose and vanadium levels. Mean blood glucose levels were 83+/-1% and 109+/-1% of the starting values for animals iontophoretically treated with bpV(phen) and vehicle, respectively. The compound's insulin mimetic properties were evident within 60 min of current initiation. Blood glucose levels were reduced to 74+/-14% of the original level after 16 h of passive treatment. The compound was ineffective when fed to animals. Transdermal delivery of bpV(phen) resulted in significantly greater blood levels of vanadium than the orally delivered compound (P<0.05). Overall these experiments demonstrate that peroxovanadium delivered through the skin can lower blood glucose levels in rats. Further experiments are warranted to better characterize the nature of the response and to determine the potential for using these compounds in humans.

Administration, Cutaneous↗

Vanadium haloperoxidases.

The nature of the oxidized halogen intermediate in vanadium bromoperoxidase has recently been shown to depend on the nature of the organic substrate. For example, in the presence of indoles, vanadium bromoperoxidase does not release a freely diffusible oxidized halogen intermediate (such as HOBr+/-BR2+/-Br3-). Regioselective investigations are, therefore, now feasible.

Binding Sites↗

Vanadium K-edge absorption spectrum of bromoperoxidase from Ascophyllum nodosum.

With synchrotron radiation from the Bonn 2.5 GeV synchrotron, high-resolution absorption spectra have been measured at the vanadium K-edge of bromoperoxidase from the marine brown alga Ascophyllum nodosum and several model compounds. The near-edge structure (XANES) of these spectra was used to determine the charge state and the coordination geometry around the vanadium atom. For the active enzyme a coordination charge of 2.7 was found which is compatible with a formal valence of +5, assuming coordination by atoms with a high electronegativity such as oxygen or nitrogen. For the reduced enzyme the coordination charge value of 2.15 indicates the reduction of the valency by 1 unit. Our results suggest that the coordination sphere of the vanadium atom in the native enzyme consists of at least seven oxygen atoms in a distorted octahedral environment with an average bond length of about 2 A. Through the reduction process, the coordination sphere of the vanadium atom changes with a simultaneous decrease of the coordination cage. These results agree with those deduced from previous EPR and 51V-NMR measurements.

Eukaryota↗

Rec assay and mutagenicity studies on metal compounds.

We carried out rec assays on 127 metal compounds with Bacillus subtilis to check their DNA-damaging capacity and mutagenicity. Certain compounds of beryllium, cobalt, cesium, iridium, osmium, platinum, rhodium, antimony, tellurium, thallium and vanadium were newly found to be positive in addition to those of known positive metals such as arsenic, cadmium, chromium, mercury, molybdenum and selenium. Reverse mutation assays with Escherichia coli and Salmonella strains showed that compounds of rhodium (RhCl3), tellurium (Na2H4TeO6, Na2TeO3) and platinum (PtCl4, (NH4)2PtCl6) are potent mutagens.

Bacillus subtilis↗

A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.

In the 21st century, patients suffering from diabetes mellitus (DM), a lifestyle-related disease, will increase more than in the 20th century. DM is threatening because of the development of many severe secondary complications, including atherosclerosis, microangiopathy, renal dysfunction and failure, cardiac abnormalities, diabetic retinopathy, and ocular disorders. Generally, DM is classified as either insulin-dependent type 1 or noninsulin-dependent type 2 DM. Type 1 DM is treated only by daily insulin injections; type 2 DM is treated by several types of synthetic therapeutic substances together with a controlled diet and physical exercise. Even with these measures, the daily necessity for several insulin injections can be painful both physically and mentally, whereas the synthetic therapeutic substances used over the long term often have side effects. For those reasons, the creation and development of a new class of pharmaceuticals for treatment of DM in the 21st century would be extremely desirable. In the last half of the 20th century, investigations of the relationships among diseases and micronutrients, such as iron, copper, zinc, and selenium, have been numerous. Research into the development of metallopharmaceuticals involving the platinum-containing anticancer drug, cisplatin, and the gold-containing rheumatoid arthritis drug, auranofin, has also been widespread. Such important findings prompted us to develop therapeutic reagents based on a new concept to replace either insulin injections or the use of synthetic drugs. After many trials, we noticed that vanadium might be very useful in the treatment of DM. Before the discovery of insulin by Banting and Best in 1921 and its clinical trial for treating DM, the findings in 1899, in which orally administered sodium vanadate (NaVO(3)) was reported to improve human DM, gave us the idea to use vanadium to treat DM. However, it has taken a long time to obtain a scientific explanation as to why the metal ion exhibits insulin-mimetic or blood-glucose lowering effects in in vitro and in vivo experiments. After investigations from many perspectives involving biochemistry and bioinorganic chemistry, vanadyl sulfate (VOSO(4)) and its complexes with several types of ligands have been proposed as useful for treating DM in experimental diabetic animals. On the basis of a mechanistic study, this article reports on recent progress regarding the development of antidiabetic vanadyl complexes, emphasizing that the vanadyl ion and its complexes are effective not only in treating or relieving both types of DM but also in preventing the onset of DM.

Animals↗

Binding of vanadate to human serum transferrin.

Human serum transferrin specifically and reversibly binds 2 equiv of vanadate at the two metal-binding sites of the protein. The vanadium(V)-transferrin complex can be formed either by the addition of vanadate to apotransferrin or by the air oxidation of the vanadyl(IV)-transferrin complex. The formation of the vanadium complex can be blocked by loading the apotransferrin with iron(III), and bound vanadium can be displaced from the protein by the subsequent addition of either gallium(III) or iron(III). The binding constant for the second equiv of vanadate is 10(6.5) in 0.1 M hepes, pH 7.4 at 25 degrees C. The binding constant for the first equiv of vanadate is probably very similar, although no quantitative value could be determined. Although transferrin reacts with the vanadate anion, studies on the transferrin model compound ethylenebis(o-hydroxyphenylglycine) indicate that at pH 9.5, the vanadium is binding at the metal-binding site as a dioxovanadium(V) cation coordinated to two phenolic residues at each binding site. This bound cation appears to be protonated over the pH range 9.5-6.5, as shown by changes in the difference uv spectrum of the transferrin complex, to produce an oxohydroxo species. Further decreases in the pH lead to dissociation of the vanadium-transferrin complex.

Binding Sites↗

Vanadium-catalyzed selenide oxidation with in situ[2,3] sigmatropic rearrangement (SOS reaction): scope and asymmetric applications.

A vanadium-catalyzed method for the oxidation of prochiral aryl, allylic selenides with tandem [2,3] sigmatropic rearrangement has been developed. This protocol has been screened on a series of substrates to test for its generality and effectiveness. The applicability of this methodology to the synthesis of enantiomerically enriched allylic alcohols has been studied on a series of chiral oxazole-containing systems with a diastereomeric ratio (d.r.) of up to 85 : 15. The chiral transfer observed in the allyl alcohol products is the result of a net 1,9- and/or 1,10-induction. Finally, the first example of a selenium-oxygen nonbonding interaction in oxazole-containing selenide appears to have been observed via X-ray crystal analysis.

Catalysis↗

Vanadium salts induce cytogenetic effects in in vivo treated mice.

Three vanadium salts, vanadyl sulfate (SVO5), sodium orthovanadate (Na3VO4) and ammonium metavanadate (NH4VO3), were tested for induction of genotoxic effects in bone marrow of mice following intragastric treatment. Micronucleus (MN) induction in polychromatic erythrocytes (PCEs), structural (sCA) and numerical (nCA) chromosome aberrations in bone marrow cells were evaluated. The micronucleus test, performed at different harvesting times (0-72 h), was found to be positive for all compounds tested. In contrast, except for vanadyl sulfate, no difference was found between controls and treated animals in the sCA test performed 24 and 36 h after treatment. At the same sampling intervals, second metaphases (M II) were positively scored for nCA induction for all three vanadium salts. In addition, the frequency of hypoploid and hyperploid cells was shown to be statistically different from the control value. Polyploid cells were also induced by all compounds, but their frequency was not statistically significant. The positive results obtained by nCA analysis support the finding of a significant presence of types of micronuclei that are probably aneuploidy-related. This finding was further supported by the successful classification of such micronuclei on the basis of shape and size according to Tinwell and Ashby (1991) during microscope analysis.

Animals↗

Vanadium-iron-sulfur clusters containing the cubane-type [VFe3S4] core unit: synthesis of a cluster with the topology of the PN cluster of nitrogenase.

A synthetic method affording a topological analogue of the electron-transfer P-cluster of nitrogenase (Fe(8)S(7)(mu(2)-S(Cys))(2)) in the P(N) state has been devised, based in part on our previous development of cubane-type VFe(3)S(4) clusters (Hauser, C.; Bill, E.; Holm, R. H. Inorg. Chem. 2002, 41, 1615-1624). The cluster [(Tp)VFe(3)S(4)Cl(3)](2-) (1) is converted to [(Tp)VFe(3)S(4)(PR(3))(3)](1+) (R = Et (2), Bu (3)) by reaction with R(3)P. The phosphine ligands are readily substituted, leading to [(Tp)VFe(3)S(4)(SR)(3)](2-) (R = Ph (4), H (5)). Reduction of 2 or 3 with cobaltocene produces the edge-bridged double cubanes [(Tp)(2)V(2)Fe(6)S(8)(PR(3))(4)] (R = Et (6), Bu (7)), which are readily converted to [(Tp)(2)V(2)Fe(6)S(8)(SPh)(4)](4-) (8). The structures of clusters 3-5 and 8 were proven crystallographically. Cluster 8 has the double-cubane structure previously shown for 6, in which two cubane units are bridged by two Fe-(mu(4)-S) bonds. (57)Fe isomer shifts are consistent with the formulation [VFe(2.33+)(3)S(4)](2+) for the single cubanes and the all-ferrous description 2[VFe(2+)(3)S(4)](1+) for the double cubanes. Reaction of 6 with 4 equiv of (Et(4)N)(HS) in acetonitrile results in the insertion of sulfide with concomitant structural rearrangement and the formation of [(Tp)(2)V(2)Fe(6)S(9)(SH)(2)](4-) (10), obtained in ca. 50% yield as the Et(4)N(+) salt. The cluster has C(2) symmetry, with two all-ferrous VFe(3)S(4) fragments bridged by a common mu(6)-S atom and two mu(2)-S atoms that simulate the bridging atoms in the two Fe-(mu(2)-S(Cys))-Fe bridges of the P(N) cluster. The bridge pattern V(2)Fe(6)(mu(2)-S)(2)(mu(3)-S)(6)(mu(6)-S) and cluster shape match those of the native cluster. A best-fit superposition of the cores of 10 and the P(N) cluster affords a weighted rms deviation in atom positions of 0.33 A. Cluster 10 and [(Tp)(2)Mo(2)Fe(6)S(9)(SH)(2)](3-), prepared by a related route (Zhang, Y.; Holm, R. H. J. Am. Chem. Soc. 2003, 125, 3910-3920), demonstrate that the topology of the P(N) cluster can be achieved in molecular form in the absence of protein structure (Tp = tris(pyrazolyl)hydroborate).

Crystallography, X-Ray↗

Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.

The effect of vanadium oxides on living systems may involve the in vivo conversion of vanadate and vanadyl ions. The addition of 5 mM orthovanadate (VO4(3-), V(V)), a known inhibitor of the (Na,K)-ATPase, to yeast cells stopped growth. In contrast, the addition of 5 mM vanadyl (VO2+, V(IV) stimulated growth. Orthovanadate addition to whole cells is known to stimulate various cellular processes. In yeast, both ions inhibited the plasma membrane Mg2+ ATPase and were transported into the cell as demonstrated with [48V]VO4(3-) and VO2+. ESR spectroscopy has been used to measure the cell-associated paramagnetic vandyl ion, while 51V NMR has detected cell-associated diamagnetic vanadium (e.g. V(V)). Cells were exposed to both toxic (5 mM) and nontoxic (1 mM) concentrations of vanadate in the culture medium. ESR showed that under both conditions, vanadate became cell associated and was converted to vanadyl which then accumulated in the cell culture medium. 51V NMR studies showed the accumulation of new cell-associated vanadium resonances identified as dimeric vanadate and decavanadate in cells exposed to toxic amounts of medium vanadate (5 mM). These vanadate compounds did not accumulate in cells exposed to 1 mM vanadate. These studies confirm that the inhibitory form of vanadium usually observed in in vitro experiments is vanadate, in one or more of its hydrated forms. These data also support the hypothesis that the stimulatory form of vanadium usually observed in whole cell experiments is the vanadyl ion or one or more of its liganded derivatives.

Biological Transport↗

In vitro effect of free and complexed indium(III) against Mycobacterium tuberculosis.

In mycobacteria, the study of inhibition by metal ions has been limited by the absence of suitable molecular vectors. Recently, we reported on the inhibitory activity of a family of chelators, macrocyclic compounds (MCC), against Mycobacterium tuberculosis. In this study equimolar concentrations of the free cations vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III), and as 1:1 complexes with the MCC 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetra-acetic acid (TETA) were tested in vitro against M. tuberculosis using the Bactec 460 TB radiometric technology (Becton-Dickinson, MD, USA). Radiometric inhibition above 80% was obtained with free indium(III) and bismuth(III), and ranged from 80% to 99%, with the complexes of TETA with vanadium(IV), bismuth(III) and indium(III), in the order of increasing activity. The highest radiometric inhibition levels were obtained with the [In(TETA)]- complex, which caused drops of up to 4 log units in cellular viability. The minimal inhibitory concentration of this compound was evaluated at 3 microM.

Anti-Bacterial Agents↗

Naked (C5Me5)2M cations (M = Sc, Ti, and V) and their fluoroarene complexes.

The ionic metallocene complexes [Cp*(2)M][BPh(4)] (Cp* = C(5)Me(5)) of the trivalent 3d metals Sc, Ti, and V were synthesized and structurally characterized. For M = Sc, the anion interacts weakly with the metal center through one of the phenyl groups, but for M = Ti and V, the cations are naked. They each contain one strongly distorted Cp* ligand, with one (V) or two (Ti) agostic C-H...M interactions involving the Cp*Me groups. For Sc and Ti, these Lewis acidic species react with fluorobenzene and 1,2-difluorobenzene to yield [Cp*(2)M(kappaF-FC(6)H(5))(n)][BPh(4)] (M = Sc, n = 2; M = Ti, n = 1) and [Cp*(2)M(kappa(2)F-1,2-F(2)C(6)H(4))][BPh(4)], the first examples of kappaF-fluorobenzene and kappa(2)F-1,2-difluorobenzene adducts of transition metals. With the perfluorinated anion [B(C(6)F(5))(4)](-), both Sc and Ti form [Cp*(2)M(kappa(2)F-C(6)F(5))B(C(6)F(5))(3)] contact ion pairs. The nature of the metal-fluoroarene interaction was studied by density functional theory (DFT) calculations and by comparison with the corresponding tetrahydrofuran (THF) adducts and was found to be predominantly electrostatic for all metals studied.

Cations↗

Effects of sulphonylureas on spontaneous motility and induced contractions in rat isolated uterus.

To clarify the action of sulphonylureas on calcium, the effect of tolbutamide and glibenclamide has been investigated on a Ca-dependent process, the contractile activity of uterine smooth muscle. Both sulphonylureas antagonized the contractions evoked by CaCl2 in a non-competitive manner when the uterus was maintained in depolarizing solution and did not affect the spontaneous contractions of rat uterus. The capacity of tolbutamide and glibenclamide to relax vanadate-induced contraction of rat uterus in Ca-free medium suggests that sulphonylureas may have an intracellular site of action related to cytosolic free Ca levels, or effect a reduction in Ca action.

Animals↗

[Epidemiology of arterial hypertension and various characteristics of mineral metabolism among nomadic stock breeders in Tuva].

To reveal cardiovascular abnormalities, a screening was made in Tuva, which covered 1481 nomadic stock breeders, 1041 settled natives and 1081 migrants. The incidence of arterial hypertension (AH) was 33.5% among the nomadic stock breeders and 17.2% among the settled Tuva habitants and migrants. No impact of obesity and dyslipoproteinemia on the incidence of AH was found in the nomadic stock breeders. There was a direct correlation between the incidence of AH and alcoholization and an inverse correlation between its incidence and smoking in nomadic stock breeders aged 50-59 years. The hairs from the nomadic stock breeders exhibited elevated levels of aluminium, chromium, manganese, iron, and vanadium, which is not attributable to higher levels of these compounds in the meat of domestic animals.

Adult↗